Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

ASC30

A Study to Evaluate the Efficacy, Safety, and Tolerability in Participants With Obesity or Overweight With Weight-Related Comorbidities

Ascletis Pharma (China) Co · Phase 2 · Completed · Enrollment 125

NCT07002905

ArmPopulationDoseWeeksEstimandWeight change
Cohort 1Obesity or overweightn/rn/rn/rn/r
Cohort 2Obesity or overweightn/rn/rn/rn/r
Cohort 3Obesity or overweightn/rn/rn/rn/r
Cohort 4Obesity or overweightn/rn/rn/rn/r
Cohort 5Obesity or overweightn/rn/rn/rn/r
Cohort 6Obesity or overweightn/rn/rn/rn/r
Cohort 7Obesity or overweightn/rn/rn/rn/r